340B Report Publisher and Chief Executive Officer Ted Slafsky makes three big predictions for the 340B program for 2022 in his latest monthly column for Omnicell’s blog.

Three Big Predictions for the 340B Program in 2022

In his monthly column for Omnicell’s blog, 340B Report Publisher and Chief Executive Officer Ted Slafsky makes three big predictions for the 340B program for 2022. They focus on:

  • the U.S. Supreme Court case on Medicare reimbursement to 340B hospitals
  • where the contract pharmacy standoff is ultimately headed
  • next steps in the effort by 340B providers to challenge what they perceive as discriminatory reimbursement by third party payors as well as the congressional effort to establish a neutral clearinghouse to resolve the duplicate discount challenge.

You can read the piece here.

+ posts
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report